1. Home
  2. VANI vs ROMA Comparison

VANI vs ROMA Comparison

Compare VANI & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • ROMA
  • Stock Information
  • Founded
  • VANI 1998
  • ROMA 2018
  • Country
  • VANI United States
  • ROMA Hong Kong
  • Employees
  • VANI N/A
  • ROMA N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ROMA Savings Institutions
  • Sector
  • VANI Health Care
  • ROMA Finance
  • Exchange
  • VANI Nasdaq
  • ROMA Nasdaq
  • Market Cap
  • VANI 68.1M
  • ROMA 45.3M
  • IPO Year
  • VANI 2014
  • ROMA 2024
  • Fundamental
  • Price
  • VANI $1.26
  • ROMA $3.20
  • Analyst Decision
  • VANI Strong Buy
  • ROMA
  • Analyst Count
  • VANI 1
  • ROMA 0
  • Target Price
  • VANI $4.00
  • ROMA N/A
  • AVG Volume (30 Days)
  • VANI 146.6K
  • ROMA 270.0K
  • Earning Date
  • VANI 08-12-2025
  • ROMA 08-01-2025
  • Dividend Yield
  • VANI N/A
  • ROMA N/A
  • EPS Growth
  • VANI N/A
  • ROMA N/A
  • EPS
  • VANI N/A
  • ROMA N/A
  • Revenue
  • VANI N/A
  • ROMA $1,029,120.00
  • Revenue This Year
  • VANI N/A
  • ROMA N/A
  • Revenue Next Year
  • VANI N/A
  • ROMA N/A
  • P/E Ratio
  • VANI N/A
  • ROMA N/A
  • Revenue Growth
  • VANI N/A
  • ROMA N/A
  • 52 Week Low
  • VANI $0.91
  • ROMA $0.46
  • 52 Week High
  • VANI $1.50
  • ROMA $4.14
  • Technical
  • Relative Strength Index (RSI)
  • VANI 58.97
  • ROMA 58.38
  • Support Level
  • VANI $1.24
  • ROMA $2.91
  • Resistance Level
  • VANI $1.33
  • ROMA $3.44
  • Average True Range (ATR)
  • VANI 0.06
  • ROMA 0.29
  • MACD
  • VANI 0.00
  • ROMA -0.01
  • Stochastic Oscillator
  • VANI 59.09
  • ROMA 72.73

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for its clients' organizations and the world.

Share on Social Networks: